Literature DB >> 11069836

Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis.

D K Shum1, S C Chan, M S Ip.   

Abstract

Neutrophil-mediated degradation of bronchial matrix has been proposed as a pathogenetic factor in bronchiectasis. We hypothesize that neutrophils, found in abundance in the bronchial lumens of patients with bronchiectasis, are capable of degrading lung matrix proteoglycans and that proinflammatory mediators in bronchial secretions of these patients can enhance the degradative action of neutrophils. We used rat bronchoalveolar proteoglycans entrapped in polyacrylamide gel beads as a substrate for test incubations with neutrophils from healthy volunteers and sputum sol from patients with idiopathic bronchiectasis. Coincubations with specimens of sputum sol and neutrophils showed proteoglycan degradation indices (PDIs) in excess of the sum of indices due to incubation with either heat-inactivated sputum sol or heat-inactivated neutrophils, suggesting sputum stimulation of the neutrophil response. Mediation of this stimulation by tumor necrosis factor (TNF)-alpha was suggested because (1) indices for the coincubations correlated with sputum levels of TNF-alpha and (2) an anti-TNF-alpha antibody completely attenuated the sputum-stimulated effect. Furthermore, recombinant human TNF-alpha required accompanying sputum sol to exert an enhancing effect on neutrophil-mediated proteoglycan degradation. Because neutrophil-mediated proteoglycan degradation in the coincubations was inhibited largely (90%) by Eglin C and much less so (8% to 20%) by ethylenediamine tetraacetic acid, we conclude that serine proteases secreted by neutrophils were mainly responsible for degradation of proteoglycans in the model matrix and that the secretion was stimulated by TNF-alpha in the presence of cofactors in the bronchial secretions of patients with bronchiectasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069836     DOI: 10.1164/ajrccm.162.5.9907064

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Mechanical properties of the extracellular matrix of the aorta studied by enzymatic treatments.

Authors:  Jan-Willem M Beenakker; Brian A Ashcroft; Jan H N Lindeman; Tjerk H Oosterkamp
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

2.  IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice.

Authors:  Patricia J Dubin; Jay K Kolls
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-10-27       Impact factor: 5.464

3.  Non-cystic fibrosis bronchiectasis: review and recent advances.

Authors:  Galit Livnat; Lea Bentur
Journal:  F1000 Med Rep       Date:  2009-08-26

4.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

5.  Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis.

Authors:  A P Watt; V Brown; J Courtney; M Kelly; L Garske; J S Elborn; M Ennis
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

Review 6.  Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.

Authors:  Jürgen Schäfer; Matthias Griese; Ravishankar Chandrasekaran; Sanjay H Chotirmall; Dominik Hartl
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

Review 7.  Research advances and clinical management of bronchiectasis: Chinese perspective.

Authors:  Jin-Fu Xu; Yong-Hua Gao; Yuan-Lin Song; Jie-Ming Qu; Wei-Jie Guan
Journal:  ERJ Open Res       Date:  2022-04-11

8.  The immune response and its therapeutic modulation in bronchiectasis.

Authors:  Massoud Daheshia; James D Prahl; Jacob J Carmichael; John S Parrish; Gilbert Seda
Journal:  Pulm Med       Date:  2012-10-10

Review 9.  The Role of the Immune Response in the Pathogenesis of Bronchiectasis.

Authors:  Paul T King
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.